STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities:
Net income (loss)	$ 22,637	$ 21,186	$ (9,556)
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:
Depreciation and amortization expense	2,942	1,924	1,424
Deferred income taxes	(7,320)	(732)	(3,732)
Non-cash operating lease cost	2,863	2,381	0
Stock-based compensation	45,799	37,458	81,139
Accretion of discount on available-for-sale securities	(1,678)	0	0
Changes in operating assets and liabilities:
Accounts receivable	(603)	(4,425)	3,339
Inventory	58,936	(91,908)	(36,333)
Prepaid expenses and other current assets	(572)	(4,483)	(735)
Other assets	(79)	(197)	127
Accounts payable	(6,192)	6,315	2,855
Accrued expenses	(18,657)	1,487	17,983
Accrued compensation and benefits	3,897	(3,049)	2,250
Sales tax payable	(225)	(354)	652
Gift card liability	358	2,292	2,571
Deferred revenue	(626)	2,190	(1,185)
Returns reserve	(469)	697	1,084
Income tax payable	2,557	(3,973)	4,428
Deferred rent and lease incentive	0	0	(117)
Operating lease liabilities	(2,660)	(2,071)	0
Other non-current liabilities	7	(67)	243
Net cash (used in) provided by operating activities	100,915	(35,329)	66,437
Cash flows from investing activities:
Purchases of property and equipment	(16,348)	(5,348)	(2,712)
Purchases of available-for-sale securities	(150,139)	0	0
Maturities of available-for-sale securities	49,300	0	0
Purchases of held-to-maturity securities	0	(500)	0
Net cash used in investing activities	(117,187)	(5,848)	(2,712)
Cash flows from financing activities:
Proceeds from issuance of Class A common stock in initial public offering, net of underwriting discounts	0	0	95,881
Payments of initial public offering issuance costs, net of reimbursements	0	0	(780)
Payment of debt issuance and financing costs	0	0	(181)
Proceeds from capital contributions	0	479	1,301
Proceeds from stock option exercises and employee stock purchases	916	3,043	907
Tax payments related to net share settlements on restricted stock units	(246)	0	(21,556)
Net cash provided by financing activities	670	3,522	75,572
Net (decrease) increase in cash, cash equivalents, and restricted cash	(15,602)	(37,655)	139,297
Cash, cash equivalents, and restricted cash, beginning of period	159,775	197,430	58,133
Cash, cash equivalents, and restricted cash, end of period	144,173	159,775	197,430
Supplemental disclosures:
Cash paid for income taxes, net of refunds received	21,100	11,903	15,004
Property and equipment included in accounts payable and accrued expenses	453	19	32
Deferred offering costs recorded in stockholders’ equity upon initial public offering, net of related tax impacts	$ 0	$ 0	$ 220